UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000002040
Receipt number R000002447
Scientific Title The effects of a calorie intake on an energy metabolism in patients with chronic liver diseases
Date of disclosure of the study information 2009/07/01
Last modified on 2017/04/01 20:08:22

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The effects of a calorie intake on an energy metabolism in patients with chronic liver diseases

Acronym

A calorie intake and an energy metabolism in chronic liver diseases

Scientific Title

The effects of a calorie intake on an energy metabolism in patients with chronic liver diseases

Scientific Title:Acronym

A calorie intake and an energy metabolism in chronic liver diseases

Region

Japan


Condition

Condition

Chronic liver diseases

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The objects of this study are as follows;
1)whether a reduction of calorie intake after admission leads to a decrease of non-protein respiratory quotient (npRq)
2)whether a maintenance of calorie intake at home prohibits a reduction of npRq after admission
3)whether an administration of branched-chain amino acids before sleep (late evening snack; LES) improves npRq in a group taking a calorie normalized to resting energy expenditure
4)whether thre are significant correlation between nrRq and subclinical hepatic encephalopathy
5)whether LES is effective for subclinical hepatic encephalopathy
6)whether an improvement after treatments for hepatocellular carcinoma depends on npRq

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Phase II,III


Assessment

Primary outcomes

1)non-protein respiratory quotient
2)neuro-psychological test
3homeostasis model assessment of insulin resistance
4)nitrogen balance
5)Branched-chain amino acid/Tyrosine molar ratio
6)hospital days

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Placebo

Stratification

YES

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

YES

Concealment

Central registration


Intervention

No. of arms

6

Purpose of intervention

Prevention

Type of intervention

Medicine

Interventions/Control_1

Noramal calorie intake at home,
Keep the calorie at home after admission,
No additional branched-chain amino acids

Interventions/Control_2

Noramal calorie intake at home,
Keep the calorie at home after admission,
Additional branched-chain amino acids

Interventions/Control_3

Exceeded calorie intake at home,
Keep the calorie at home after admission,
No additional branched-chain amino acids

Interventions/Control_4

Exceeded calorie intake at home,
Keep the calorie at home after admission,
Additional branched-chain amino acids

Interventions/Control_5

Exceeded calorie intake at home,
Normalize the calorie at home after admission,
No additional branched-chain amino acids

Interventions/Control_6

Exceeded calorie intake at home,
Normalize the calorie at home after admission,
Additional branched-chain amino acids

Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1)A therapy for hepatocellular carcinomas is conducted under addmission in our hospital
2)Performance States 0-2
3)An informed concent was obtained in a written form from the patient

Key exclusion criteria

1) Calorie intake at home are lower than 80% of standard calorie estimated from Harris-Benedict formula.
2) The concentration of creatinine in the serum was more than 2.0 mg/dl.
3) Allergic reaction was evoked by milk.
4) Hasegawa Dementia Scale revealed an overt dementia
5) Technically it is hard to perform a neuro-psychological test
6) An attending doctor judged inadequate due to any reason


Target sample size

120


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Takeshi Suda

Organization

Niigata University Graduate School of Medical and Dental Sciences

Division name

Department of Gastroenterology and Hepatology

Zip code


Address

1-757 Asahi-Machi, Chuo-Ku, Niigata, Niigata 951-8122

TEL

025-227-2207

Email

tspitt@med.niigata-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Tsutomu Kanefuji

Organization

Niigata Liver Metabolism Study Group

Division name

Excuteive office

Zip code


Address

1-757 Asahi-Machi, Chuo-Ku, Niigata, Niigata 951-8122

TEL

025-227-2207

Homepage URL


Email

kanefuji1229@gmail.com


Sponsor or person

Institute

Niigata Liver Metabolism Study Group

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

None

Name of secondary funder(s)

None


IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2009 Year 07 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2009 Year 06 Month 26 Day

Date of IRB


Anticipated trial start date

2009 Year 07 Month 01 Day

Last follow-up date

2013 Year 03 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2009 Year 06 Month 03 Day

Last modified on

2017 Year 04 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000002447


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name